Speaker: Rahul Krishnatry, MD, Tata Memorial Centre
Rahul Krishnatry, MD: Hi, I am Rahul Krishna from Tata Memorial Centre Mumbai in India. I'll be presenting two abstracts on first of October Tuesday afternoon poster session. The first abstract is basically development of organ at risk dose constraints for proton-based IMPT in anal cancer. The dose constraints achieved in this will be used for a prospective phase three randomized trial to compare proton versus photon treatment for anal cancer. The second abstract is for a trial in progress which is a phase two double blinded randomized trial for non-operative management suitable rectal cancer patients receiving short course-based TNT with brachytherapy. These patients will be randomized with chlorophyll 'yes" or "no" for decreasing the overall toxicity rates. I hope you would be interested in this work and would attend to our posters. Thank you.
